医学
溃疡性结肠炎
乌斯特基努马
内科学
白细胞介素1受体拮抗剂
白细胞介素23
维多利祖马布
真实世界数据
白细胞介素
受体拮抗剂
敌手
受体
疾病
细胞因子
阿达木单抗
数据科学
计算机科学
作者
Antonio Tursi,Giammarco Mocci,Franco Scaldaferri,Daniele Napolitano,Rossella Maresca,Daniela Pugliese,Gianluca Semprucci,Edoardo Savarino,Antonio Cuomo,L. Donnarumma,Giorgia Bodini,Andrea Pasta,Giovanni Maconi,Giovanni Cataletti,Giuseppe Pranzo,Stefano Rodinò,Ladislava Sebkova,Francesco Costa,Antonio Ferronato,Federica Gaiani
标识
DOI：10.1080/14712598.2024.2309300
摘要
Background Ustekinumab (UST) is an interleukin-12/interleukin-23 receptor antagonist recently approved for treating ulcerative colitis (UC) but with limited real-world data. Therefore, we evaluated the effectiveness and safety of UST in patients with UC in a real-world setting.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
CAOHOU
yx_cheng
Nico
乐乐乐乐乐乐
23
eric888
核桃
勤劳的猕猴桃
代芙
鬼见愁
Sandy
YifanWang
CJ
GingerF
aldehyde
lanxinyue
COSMAO
FIN
leinei
比比谁的速度快
皖公网安备34019202002308
